Business Context and Reporting Period
This Form 8-K Current Report was filed by National Health Investors, Inc. (NHI) on February 17, 2026. The filing addresses corporate governance changes, specifically the appointment of a new director and the resignation and reappointment of the Chief Executive Officer as a director to align with a newly declassified board structure.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and contains no financial performance data.
Material Changes
- Board Expansion: The Board of Directors increased its size and appointed Lilly H. Donohue to fill a vacant seat, effective immediately. Her initial term expires at the 2026 Annual Meeting.
- CEO Director Resignation and Reappointment: D. Eric Mendelsohn, President and CEO, resigned as a director effective immediately. The Board accepted the resignation and immediately reappointed him as a director to serve until the 2026 Annual Meeting.
- Board Structure Change: These actions facilitate the transition to a fully declassified board, where all directors will stand for election to one-year terms at the 2026 Annual Meeting.
Guidance, Outlook, and Management Commentary
Management Commentary: Mr. Mendelsohn stated his resignation was intended to align his directorship term with the Company's newly declassified board structure. He expressed willingness to be reappointed and stand for election at the 2026 Annual Meeting.
Compensation: Ms. Donohue will receive compensation in accordance with the Company's standard arrangements for non-employee directors, as detailed in the 2025 proxy statement. No special transactions or arrangements were disclosed.
Risks and Contingencies: The filing does not disclose new risks, contingencies, or unusual items beyond the standard governance transition.
Key Facts for Investor Verification
- Verify the full background and potential conflicts of interest for new director Lilly H. Donohue, particularly her current role as CEO of Everstory Partners and prior experience in senior living and private equity.
- Confirm the timeline for the 2026 Annual Meeting to understand when the board declassification will be fully realized.
- Review the Company's 2025 proxy statement (filed April 7, 2025) for details on the standard compensatory arrangements applicable to Ms. Donohue.
- Monitor future filings for the results of the 2026 Annual Meeting regarding the election of directors.